Femring and post procedural complication 
Femring and post procedural complication Patient Reports February 10, 2010
Femring Side Effects Report #4790441-5
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 21, 2005. Female patient, 63 years of age, weighting 149.9 lb, was diagnosed with menopausal symptoms and was treated with Femring. After drug was administered, patient experienced the following side effects: ileal perforation, intestinal obstruction, post procedural complication, sepsis
, white blood cell count increased. Femring dosage: 0.1 MG, QD, VAGINAL. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, ALTACE. Patient was hospitalized. Patient recovered.Femring Side Effects Report #4920806-X
Femring side effect was reported by a Physician from UNITED STATES on May 13, 2004. Female patient, 61 years of age, weighting 155.9 lb, was diagnosed with menopausal symptoms and was treated with Femring. After drug was administered, patient experienced the following side effects: dyspareunia, hyperkeratosis, medical device complication, post procedural complication, rectocele, vaginal disorder, vaginal infection. Femring dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with LIPITOR, PREMARIN, CALCIUM, ACTONEL. Patient recovered.
Femring Side Effects Report #4643354-3
Femring side effect was reported by a Consumer or non-health professional from on Apr 11, 2005. Female patient, 52 years of age, weighting 173.1 lb, was diagnosed with menopausal symptoms and was treated with Femring. After drug was administered, patient experienced the following side effects: diarrhoea, fall
, foot fracture, migraine , migration of implant, motion sickness , post procedural complication, pulmonary thrombosis. Femring dosage: unknown. During the same period patient was treated with VIOXX, PREDNISONE, REMICADE, PREVACID, ZANTAC, IMITREX, BEXTRA. Patient was hospitalized. Patient recovered.Femring Side Effects Report #4643354-3
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2005. Female patient, 52 years of age, weighting 173.1 lb, was diagnosed with menopausal symptoms and was treated with Femring. After drug was administered, patient experienced the following side effects: device migration, diarrhoea, fall
, foot fracture, migraine , motion sickness , post procedural complication, pulmonary thrombosis. Femring dosage: unknown. During the same period patient was treated with VIOXX, PREDNISONE, REMICADE, PREVACID, ZANTAC, IMITREX, BEXTRA. Patient was hospitalized. Patient recovered.